Renal Allograft Tolerance Through Mixed Chimerism - SMC/MGH
Status:
Not yet recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
The goal is to investigate the safety of the conditioning regimen, and its ability to induce
donor/recipient lymphohematopoietic chimerism without Chimerism Transition Syndrome (CTS),
which may result in donor-specific unresponsiveness (tolerance) to the renal allograft in the
absence of maintenance immunosuppression.